Researchers discover new vein of cancer-fighting agents

Canstantin inhibits new blood vessel growth, suppresses renal, prostate tumor growth in mice

BOSTON--Researchers at Beth Israel Deaconess Medical Center have discovered a potent new substance that thwarts tumor growth by blocking the formation and growth of new blood vessels. The naturally occurring protein is named "canstatin" for its potential cancer-halting abilities.

In a mouse model of human prostate cancer, canstatin was as effective at less than half the dose as the well-known angiogenic inhibitor endostatin in halting the growth of tumors. In mice models of renal cancer, canstatin stopped the growth or slightly shrank tumors to as much as one-fourth the size of tumors in mice treated with a placebo. The paper is published in the Jan. 14 issue of the Journal of Biological Chemistry (published online Jan. 7 at www.jbc.org ).

This is the first in a series of new angiogenic inhibitors discovered in the blood vessel wall by BIDMC researcher Raghu Kalluri and his colleagues. In addition to its preliminary promise as a cancer-fighting agent, canstatin is also relatively easy to produce in quantities that will be necessary for human clinical trials, which may begin in one or two years after further preclinical testing.

"Tumors are highly dependent on new blood vessels for their growth, and canstatin appears to stop the division of endothelial cells as they begin multiplying to form new blood vessels," says Kalluri, who is also an assistant professor of medicine at Harvard Medical School. "The agent stops them from multiplying by inducing programmed cell death only in the dividing cells, not in the non-dividing endothelial cells in established blood vessels. The tumor stops growing because it doesn't get any new blood supply or nutrients."

During the process of angiogenesis, endothelial cells that line inside of the blood vessel divide, move through the surr

Contact: Carol Cruzan Morton
Beth Israel Deaconess Medical Center

Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:

(Date:8/7/2018)... (PRWEB) , ... August 07, 2018 , ... CallTower ... today their new CT Cloud Voice and SIP solutions. CT Cloud solutions are ... secure, quality voice solution that is far superior to traditional PBX systems, at a ...
(Date:8/1/2018)... ... August 01, 2018 , ... Dr. Asher Kimchi, Founder ... winning recipients of the 2018 IAC Awards at the 23rd World Congress on Heart ... also named four faculty to receive the Distinguished Fellowship Awards. , Dr. Asher Kimchi, ...
(Date:8/1/2018)... , ... August 01, 2018 , ... Visikol CEO Dr. ... services and strong pharmaceutical company partnerships that Visikol will far exceed its original 2018 ... developing its suite of digital pathology tools, whole mount imaging ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... August 08, 2018 , ... ... was developed and is continually updated by a talented scientific team that includes ... service provides: , 1. Information on the medical impact of a patient’s ...
(Date:8/9/2018)... ... August 09, 2018 , ... Simpson ... construction (AEC) experts with building owners and managers for a full-day discussion on ... Construct symposium comes to Boston for the first time on Thursday, 13 September ...
(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ... 2 additional CE/IVD marked molecular quality controls to its expanding CE/IVD product inventory. ... controls to our expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed to fully ...
(Date:7/25/2018)... ... July 25, 2018 , ... Dimitrius Anagnos, an evidence-based ... combat inflammation and autoimmune disorders. , The preclinical research assessed biomarkers for ... was reported:, Over 70% decrease in Interleukin (IL-1ß) ...
Breaking Biology Technology:
Cached News: